Arrowhead Pharmaceuticals(ARWR) - 2025 Q3 - Quarterly Results
PRESS RELEASE August 7, 2025 Arrowhead Pharmaceuticals Reports Fiscal 2025 Third Quarter Results Conference Call and Webcast Today, August 7, 2025 at 4:30 p.m. ET PASADENA, Calif., August 7, 2025 — Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 third quarter ended June 30, 2025. The Company is hosting a conference call today, August 7, 2025, at 4:30 p.m. ET to discuss the results. "Arrowhead continues to achieve strong execution in discovery, clinical an ...